Product Images Perindopril Erbumine

The text describes a graph showing the results of a clinical trial comparing the effectiveness of Placebo and Perindopril treatment over a period of four years. The y-axis shows a logarithmic scale for p-values ranging from 0 to 0.001. The x-axis shows the time in years, labeled from 0 to 4. The plot shows two distinct curves representing the Placebo and Perindopril treatments. The plot suggests that the Perindopril treatment is significantly more effective than the Placebo treatment, with a p-value of 0.0003. The number of patients at risk for both treatments is provided for each year.*

This appears to be a tabular representation of the distribution of primary events (%), along with the number of patients, their gender, age, and various medical conditions such as hypertension, diabetes, and the use of certain drugs. The table also compares the effectiveness of perindopril versus a placebo in terms of "favors" or positive outcomes for each of the medical conditions.*

This is a description of a medication called Perindopri, which comes in tablet form and has a NDC number of 68180-255-0. The dosage and administration details can be found on the accompanying prescribing information. It is important to keep these tablets out of the reach of children, and store them at a temperature between 20°C to 25°C, while protecting them from moisture. The tablets are manufactured by Lupin Limited in Goa, India, and are distributed in the United States by Lupin Pharmaceuticals, Inc. Each tablet contains 2mg of perindopril erbumine.*

This is a drug information sheet for Perindopril Erbumine Tablets, containing the drug's National Drug Code (NDC: 68180-256-01), dosage and administration instructions, and manufacturer's information. The tablets contain 4 mg of perindopril erbumine and should be stored at 20-25°C to protect from moisture. The drug is manufactured by Lupin Pharmaceuticals, Inc. and is only available with a prescription.*

This is a prescription drug with NDC number 68180-237-01, which contains 8 mg of perindopril erbumine per tablet. It is manufactured by Lupin Limited in Goa, India and distributed by Lupin Pharmaceuticals, Inc. in Baltimore, Maryland. Dosage and administration information is available in the prescribing information. It should be stored at controlled room temperature and protected from moisture, and kept out of reach of children.*